Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
eBay
EBAY
5
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
IMOS ChipMOS TECHNOLOGIES
- 19.080
- +0.290+1.54%
Trading May 15 11:39 ET
684.25MMarket Cap14.79P/E (TTM)
19.080High18.550Low1.55KVolume18.940Open18.790Pre Close29.31KTurnover0.01%Turnover Ratio14.79P/E (Static)35.86MShares27.08352wk High0.83P/B548.83MFloat Cap12.78352wk Low1.09Dividend TTM28.76MShs Float36.700Historical High5.70%Div YieldTTM2.82%Amplitude7.431Historical Low18.932Avg Price1Lot Size
ChipMOS TECHNOLOGIES Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (FY)Dec 31, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.27%22.7B | -5.69%5.4B | -9.19%21.36B | 5.73B | -14.17%23.52B | -1.87%6.85B | 4.02%6.73B | 19.07%27.4B | 28.63%6.98B | 15.72%6.47B |
| Operating revenue | 6.27%22.7B | -5.69%5.4B | -9.19%21.36B | --5.73B | -14.17%23.52B | -1.87%6.85B | 4.02%6.73B | 19.07%27.4B | 28.63%6.98B | 15.72%6.47B |
| Cost of revenue | 10.92%19.75B | 6.76%4.88B | -4.29%17.81B | 4.58B | -7.65%18.61B | 1.86%5.11B | 2.93%5.05B | 12.05%20.15B | 16.56%5.02B | 13.61%4.9B |
| Gross profit | -17.05%2.94B | -55.23%514.8M | -27.74%3.55B | 1.15B | -32.28%4.91B | -11.40%1.74B | 7.45%1.68B | 44.15%7.25B | 74.83%1.97B | 22.89%1.56B |
| Operating expense | 1.78%1.67B | -3.01%431.6M | -3.21%1.64B | 445M | -3.26%1.7B | 4.82%485.1M | 10.01%467.1M | 10.40%1.75B | 16.22%462.8M | 11.30%424.6M |
| Selling and administrative expenses | -4.12%607.29M | ---- | -5.00%633.4M | ---- | -1.66%666.71M | ---- | ---- | 15.74%677.96M | ---- | ---- |
| -Selling and marketing expense | -5.11%128.73M | ---- | 5.96%135.66M | ---- | 73.18%128.03M | ---- | ---- | 29.75%73.93M | ---- | ---- |
| -General and administrative expense | -3.86%478.55M | ---- | -7.60%497.74M | ---- | -10.82%538.68M | ---- | ---- | 14.24%604.03M | ---- | ---- |
| Research and development costs | 6.33%1.16B | ---- | -5.62%1.09B | ---- | 1.70%1.16B | ---- | ---- | 12.18%1.14B | ---- | ---- |
| Other operating expenses | -16.23%-99.89M | ---- | 33.86%-85.94M | ---- | -100.72%-129.93M | ---- | ---- | -363.74%-64.73M | ---- | ---- |
| Operating profit | -33.25%1.27B | -83.67%116.7M | -40.67%1.91B | 714.5M | -41.53%3.22B | -17.07%1.28B | 6.26%1.23B | 59.70%5.5B | 95.10%1.54B | 30.42%1.16B |
| Net non-operating interest income expense | -10.96%-81.22M | 23.81%-73.2M | 20.73%-96.08M | 15.66%-121.2M | ||||||
| Non-operating interest income | 2.34%197.72M | ---- | 237.75%193.19M | ---- | 473.14%57.2M | ---- | ---- | -64.07%9.98M | ---- | ---- |
| Non-operating interest expense | 4.75%278.58M | ---- | 86.72%265.96M | ---- | 17.72%142.44M | ---- | ---- | -25.49%121M | ---- | ---- |
| Total other finance cost | -17.09%359K | ---- | -96.01%433K | ---- | 6.42%10.84M | ---- | ---- | 12.16%10.19M | ---- | ---- |
| Other net income (expense) | 4.93%454.34M | -52.28%432.98M | 38.46%907.27M | 299.88%655.25M | ||||||
| Gain on sale of security | 147.56%290.69M | ---- | -68.99%117.42M | ---- | 647.24%378.69M | ---- | ---- | 78.90%-69.2M | ---- | ---- |
| Earnings from equity interest | -98.78%2.68M | ---- | -51.54%219.89M | ---- | -27.49%453.72M | ---- | ---- | 524.72%625.73M | ---- | ---- |
| Special income (charges) | --72.26M | ---- | --0 | ---- | --0 | ---- | ---- | -59.84%51.93M | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --4.84M | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---891K | ---- | ---- |
| -Gain on sale of property,plant,equipment | --72.26M | ---- | --0 | ---- | --0 | ---- | ---- | -56.78%55.88M | ---- | ---- |
| Other non- operating income (expenses) | -7.27%88.7M | ---- | 27.78%95.66M | ---- | 60.00%74.87M | ---- | ---- | 156.63%46.79M | ---- | ---- |
| Income before tax | -27.39%1.65B | -43.69%2.27B | -33.26%4.03B | 2.88%1.32B | 27.69%1.22B | 102.99%6.04B | 135.57%1.28B | 7.06%959.1M | ||
| Income tax | -30.98%207.52M | -48.88%300.66M | -46.45%588.18M | 84.78%1.1B | ||||||
| Net income | -26.84%1.44B | -51.83%232.2M | -42.80%1.97B | 482M | -30.33%3.44B | 2.88%1.32B | 27.69%1.22B | 107.54%4.94B | 135.57%1.28B | 34.57%959.1M |
| Net income continuous Operations | -26.84%1.44B | -51.83%232.2M | -42.80%1.97B | --482M | -30.33%3.44B | 2.88%1.32B | 27.69%1.22B | 107.54%4.94B | 135.57%1.28B | 34.57%959.1M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -26.84%1.44B | -51.83%232.2M | -42.80%1.97B | 482M | -30.33%3.44B | 2.88%1.32B | 27.69%1.22B | 107.54%4.94B | 135.57%1.28B | 34.57%959.1M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -26.84%1.44B | -51.83%232.2M | -42.80%1.97B | 482M | -30.33%3.44B | 2.88%1.32B | 27.69%1.22B | 107.54%4.94B | 135.57%1.28B | 34.57%959.1M |
| Basic earnings per share | -26.94%39.6 | -51.52%6.4 | -42.71%54.2 | 13.2 | -30.34%94.6 | 3.41%36.4 | 27.27%33.6 | 107.65%135.8 | 134.67%35.2 | 34.69%26.4 |
| Diluted earnings per share | -26.87%39.2 | -51.52%6.4 | -42.12%53.6 | 13.2 | -30.38%92.6 | 2.27%36 | 27.69%33.2 | 105.88%133 | 134.67%35.2 | 34.02%26 |
| Dividend per share | -23.57%35.7265 | 0 | -45.23%46.7418 | 0 | 93.55%85.3443 | 85.3443 | 0 | 22.09%44.0949 | 0 | 0 |
| Currency Unit | TWD | TWD | TWD | TWD | TWD | TWD | TWD | TWD | TWD | TWD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now